Steroidal Antiestrogen Fulvestrant Anti Cancer Drug WC Avai 129453-61-8
Contact Person : Jimmy Tian
Phone Number : 86-18602905046
WhatsApp : +8618602905046
Detail Information |
|||
Country Of Origin: | India | Pack Size: | 1 Vial |
---|---|---|---|
Storage Conditions: | Store At Room Temperature | Warnings: | Do Not Use In Pregnant Or Breastfeeding Women |
Contraindications: | Hypersensitivity To The Active Substance Or To Any Of The Excipients | Indication: | Treatment Of Hormone Receptor-positive Metastatic Breast Cancer |
Shelf Life: | 36 Months | Manufacturer: | Pfizer |
High Light: | Fulvestrant Pharmaceutical Intermediates,1 Vial Pack Fulvestrant Injection,Breast Cancer Treatment Fulvestrant Injection |
Product Description
Fulvestrant Injection, also known as Faslodex Injection, is a product of Pfizer, a world-leading research-based pharmaceutical company. This injection contains Fulvestrant, which is an estrogen receptor antagonist used in the treatment of postmenopausal women with advanced or metastatic breast cancer. It is effective in reducing the progression of certain types of breast cancer. However, it should not be used in pregnant or breastfeeding women and people with hypersensitivity to the active substance or to any of the excipients.
This injection needs to be stored at room temperature and should be administered by a healthcare professional. Common adverse reactions to Fulvestrant Injection include nausea, vomiting, fatigue, headache, hot flashes, bone pain, arthralgia, myalgia, and anorexia. It is important to talk to a doctor before taking this injection to make sure it is safe to use.
Product Name | Fulvestrant |
---|---|
Active Ingredient | Fulvestrant |
Form | Injection |
Dosage | 250mg Intramuscularly Once Every 28 Days |
Indication | Treatment Of Hormone Receptor-positive Metastatic Breast Cancer |
Manufacturer | Pfizer |
Country of Origin | India |
Shelf Life | 36 Months |
Adverse Reactions | Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia |
Contraindications | Hypersensitivity To The Active Substance Or To Any Of The Excipients |
Fulvestrant is a faslodex injection from India with a pack size of 1 Vial. It is indicated for the treatment of hormone receptor-positive metastatic breast cancer. Contraindications include hypersensitivity to the active substance or to any of the excipients.
Fulvestrant is used to treat advanced forms of hormone receptor-positive breast cancer, which means the cancer cells are stimulated by the hormone estrogen. It works by blocking the effects of estrogen on the cancer cells and reducing their growth. Fulvestrant is usually used after other treatments, such as endocrine therapy, have failed.
Fulvestrant is also used to treat postmenopausal women with advanced disease and those who have not previously been treated with endocrine therapy. It is given as an intramuscular injection every 28 days for up to a year or more. It is important to follow your doctor's instructions for taking this medication.
Fulvestrant is a powerful medication and should only be used when other treatments have failed. It is important to discuss the risks and benefits of treatment with your doctor before starting Fulvestrant.
Fulvestrant technical support and service provides customers with the necessary information and tools to help them properly use Fulvestrant. Technical support is available through email, phone, and online chat. Customers can also access detailed product documentation, including FAQs and installation instructions. Additionally, Fulvestrant provides a wide range of customer service services, such as warranty coverage, product training, and customer satisfaction surveys.
Enter Your Message